Pediatrix Medical Group, Inc. MD is well-poised to grow on the back of a strong inorganic growth profile and solid segmental performances. Its strategy to improve brand awareness is expected to help ...
Collaboration supports co-development of RB-340, a HER-2 targeted CAR T- cell therapy with context-dependent and inducible down-regulation of PD-1, through Phase 2 HOUSTON & MENLO PARK, ...
Under the agreement, MD Anderson and TriSalus will collaborate on studies evaluating the administration of investigational SD-101 intravascularly via TriSalus’ Food and Drug Administration (FDA) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results